Crossmark

Fibroblast activation protein inhibitor (FAPI) PET imaging in pulmonary fibrosis: pathophysiology, clinical utility, and emerging theranostic applications

Crossref DOI link: https://doi.org/10.1186/s12931-026-03661-y

Published Online: 2026-04-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-waqeerah, Ali

He, Huanyu

Bashah, Ahmed

Ghaleb, Eslam

Wang, Nan

Gao, Lili
License Information

Text and Data Mining valid from 2026-04-14

Version of Record valid from 2026-06-12
More Information

Article History

Received: 1 December 2025

Accepted: 30 March 2026

First Online: 14 April 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below